Annandale Capital »

Elevation Oncology shares owned by Annandale Capital

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Annandale Capital from 13F filings

Historical chart of Annandale Capital investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Annandale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Annandale Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $27k 50k 0.54
2023-09-30 $33k 50k 0.66
2023-06-30 $76k 50k 1.52
2023-03-31 $95k 50k 1.90
2022-12-31 $48k 50k 0.96
2022-09-30 $34k 30k 1.13

More positions owned by Annandale Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Vanguard Whitehall Fds High Div Yld (VYM)
Meta Platforms Cl A (META)
Ishares Tr Us Treas Bd Etf (GOVT)
Global X Fds Glb X Mlp Enrg I (MLPX)
Uber Technologies (UBER)
Netflix (NFLX)
Ishares Tr Russell 2000 Etf (IWM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)

View all positions for Annandale Capital

Top funds holding Elevation Oncology

Advisor Group Holdings

View all funds holding Elevation Oncology